Unknown

Dataset Information

Docosahexaenoic acid (DHA) intake estimated from a 7-question survey identifies pregnancies most likely to benefit from high-dose DHA supplementation.


ABSTRACT:

Background

Two randomized trials found women with low blood docosahexaenoic acid (DHA; an omega 3 fatty acid) had fewer early preterm births (<34 weeks gestation) if they were assigned to high dose DHA supplementation, however, there is currently no capacity for clinicians who care for pregnancies to obtain a blood assessment of DHA. Determining a way to identify women with low DHA intake whose risk could be lowered by high dose DHA supplementation is desired.

Objective

To determine if assessing DHA intake can identify pregnancies that benefit from high dose DHA supplementation.

Study design

This secondary analysis used birth data from 1310 pregnant women who completed a 7-question food frequency questionnaire (DHA-FFQ) at 16.8 ± 2.5 weeks gestation that is validated

SUBMITTER: Christifano DN 

PROVIDER: S-EPMC9852746 | biostudies-literature | 2023 Feb

REPOSITORIES: biostudies-literature